Related Experiment Video

Updated: May 29, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

[PTEN: a new target in inhibiting of tumor invasion and metastasis]

Wen-Tong Liang1, Zhi-Yong Cheng, Zhi-Qiang Jia

  • 1Department of Hematology, First Hospital of Baoding, Baoding 071000, China.

Sheng Li Ke Xue Jin Zhan [Progress in Physiology]
|September 22, 2011
PubMed

Insights

The tumor suppressor gene PTEN (Phosphatase and tensin homolog) inhibits cancer invasion and metastasis. This review explores PTEN

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Context:

  • Malignant tumors are characterized by invasion and metastasis, significantly impacting treatment outcomes and patient prognosis.
  • Tumor cell dissemination involves complex interactions with the tumor microenvironment, including endothelial cells and the extracellular matrix.
  • Various signaling molecules mediate tumor cell penetration of blood vessels and degradation of extracellular matrix, facilitating metastasis.

Purpose:

  • To review the role of PTEN (Phosphatase and tensin homolog) in suppressing tumor cell invasion and metastasis.
  • To elucidate the molecular mechanisms by which PTEN regulates cellular processes critical to cancer spread.

Summary:

  • PTEN, a tumor suppressor gene, encodes a protein with dual phosphatase activity.
  • PTEN negatively regulates key signaling pathways involved in cell growth, cell cycle progression, and apoptosis.
  • PTEN actively inhibits tumor cell invasion, infiltration, and metastatic potential.

Impact:

  • Understanding PTEN's function provides insights into potential therapeutic strategies targeting cancer metastasis.
  • PTEN's role as a tumor suppressor highlights its importance in maintaining normal physiological functions and preventing tumor progression.
  • This review consolidates current knowledge on PTEN's anti-metastatic mechanisms, aiding further research in cancer therapy.

More Related Videos

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...